Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials-Reference-Cited by-同舟云学术

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials

Published:2016-03-15 Issue:1 Volume:4 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Kohrt Holbrook E., ,Tumeh Paul C.,Benson Don,Bhardwaj Nina,Brody Joshua,Formenti Silvia,Fox Bernard A.,Galon Jerome,June Carl H.,Kalos Michael,Kirsch Ilan,Kleen Thomas,Kroemer Guido,Lanier Lewis,Levy Ron,Lyerly H. Kim,Maecker Holden,Marabelle Aurelien,Melenhorst Jos,Miller Jeffrey,Melero Ignacio,Odunsi Kunle,Palucka Karolina,Peoples George,Ribas Antoni,Robins Harlan,Robinson William,Serafini Tito,Sondel Paul,Vivier Eric,Weber Jeff,Wolchok Jedd,Zitvogel Laurence,Disis Mary L.,Cheever Martin A.

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-016-0118-0.pdf

Reference124 articles.

1. Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711–23. doi: 10.1056/NEJMoa1003466 .

2. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (New York, NY). 2006;313(5795):1960–4. doi: 10.1126/science.1129139 .

3. Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(6):610–8. doi: 10.1200/jco.2010.30.5425 .

4. Broussard EK, Disis ML. TNM staging in colorectal cancer: T is for T cell and M is for memory. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(6):601–3. doi: 10.1200/jco.2010.32.9078 .

5. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306. doi: 10.1038/nrc3245 .

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond;Cancers;2024-01-23

2. The integration of machine learning and multi-omics analysis provides a powerful approach to screen aging-related genes and predict prognosis and immunotherapy efficacy in hepatocellular carcinoma;Aging;2023-07-28

3. Prospects for the Use of Metal-Based Nanoparticles as Adjuvants for Local Cancer Immunotherapy;Pharmaceutics;2023-04-27

4. The Potential Revolution of Cancer Treatment with CRISPR Technology;Cancers;2023-03-17

5. Emerging advances in engineered macrophages for tumor immunotherapy;Cytotherapy;2023-03